Efficacy of Raw Corn Starch in Insulinoma-Related Hypoglycemia:A Promising Supportive Therapy

Objective To investigate the efficacy of raw corn starch(RCS)in clinical management of insulinoma-induced hypoglycemia.Methods We retrospectively collected clinical data of insulinoma patients who received RCS-supplemented diet preoperatively,and analyzed the therapeutic effects of the RCS intervention on blood glucose control,weight change,and its adverse events.Results The study population consisted of 24 cases of insulinoma patients,7 males and 17 females,aged 46.08±14.15 years.Before RCS-supplemented diet,all patients had frequent hypoglycemic episodes(2.51±3.88 times/week),concurrent with neuroglycopenia(in 83.3% of patients)and autonomic manifestations(in 75.0% of patients),with the median fasting blood glucose(FBG)of 2.70(interquartile range[IQR]:2.50-2.90)mmol/L.The patients'weight increased by 0.38(IQR:0.05-0.65)kg per month,with 8(33.3%)cases developing overweight and 7(29.2%)cases developing obesity.All patients maintained the RCS-supplemented diet until they underwent tumor resection(23 cases)and transarterial chemoembolization for liver metastases(1 case).For 19 patients receiving RCS throughout the day,the median FBG within one week of nutritional management was 4.30(IQR:3.30-5.70)mmol/L,which was a significant increase compared to pre-nutritional level[2.25(IQR:1.60-2.90)mmol/L;P<0.001].Of them,10 patients receiving RCS throughout the day for over four weeks had sustained improvement in FBG compared to pre-treatment[3.20(IQR:2.60-3.95)mmol/L vs.2.15(IQR:1.83-2.33)mmol/L;P<0.001].Five patients who received RCS only at night also had a significant increase in FBG within one week of nutritional management[3.50(IQR:2.50-3.65)mmol/L vs.2.20(IQR:1.80-2.60)mmol/L;P<0.001],but only one patient who continued to receive RCS for over four weeks did not have a significant improvement in FBG.No improvement in weight gain was observed upon RCS supplementation.Mild diarrhea(2 cases)and flatulence(1 case)occurred,and were relieved by reduction of RCS dose.Conclusion The RCS-supplemented diet is effective in controlling insulinoma-induced hypoglycemia.

Successful management of severe hypoglycemia induced by total parenteral nutrition in patients with hepatocellular injury: Three cases reports

BACKGROUND Glucose imbalance is common in total parenteral nutrition(TPN).Hypoglycemia seems to be less frequent than hyperglycemia,but it influences the clinical outcome to a greater extent.Therefore,it should be effectively prevented and treated.However,there is no relevant report on how to treat hypoglycemia caused by TPN in patients with liver cell injury.CASE SUMMARY We present three patients with liver cell injury who developed severe hypo-glycemia during or after TPN infusion.The causes of severe hypoglycemia and glucose-raising strategies were discussed.According to the physiological charac-teristics of the hepatocellular injury,the ratio of nutrition components prescribed in TPN was appropriately adjusted for the three cases.We simultaneously reduced the dose of insulin and fat emulsion,and increased the dose of glucose in TPN.The blood glucose level was restored to normal range and clinical symptoms were eliminated.CONCLUSION When hypoglycemia occurs during or after TPN in patients with hepatocellular injury,physicians need to simultaneously reduce insulin and fat emulsion,and increase glucose,and correct severe hypoglycemia in time to reduce its adverse consequences.

Clinical profile and risk factors of symptomatic and asymptomatic hypoglycemia in neonates admitted to NICU in a tertiary care center: A cross-sectional study

Objective:To investigate the clinical profile and risk factors of symptomatic and asymptomatic hypoglycemia in neonates admitted to a neonatal intensive care unit in a tertiary care center.Methods:The prospective observational study was conducted in a tertiary care center in the Specialty Department of Pediatric.196 Newborn babies with blood glucose levels<45 mg/dL were examined with a simple random sampling method between December 2019 and November 2021.Maternal and neonatal risk factors and clinical signs were recorded and compared between symptomatic and asymptomatic cases.Results:The proportion of symptomatic hypoglycemia neonates born to gestational diabetes mellitus mothers was significantly higher(23.4%vs.8.4%)(P<0.05).Small for gestational age,low birth weight,respiratory distress syndrome,hypothermia,and endocrine disorders were risk factors.The death rate in asymptomatic hypoglycemia neonates was significantly higher(58%vs.39%)(P<0.05).Conclusions:The study indicates that maternal gestational diabetes mellitus is associated with symptomatic hypoglycemia and asymptomatic hypoglycemia is associated with neonatal mortality.It is important to take vigilance and timely interventions to address associated symptoms,particularly poor feeding,in the management of neonatal hypoglycemia.

Glucagon-like peptide-1 agonists:Role of the gut in hypoglycemia unawareness,and the rationale in type 1 diabetes

Type 1 diabetes is increasing and the majority of patients have poor glycemic control.Although advanced technology and nanoparticle use have greatly enhanced insulin delivery and glucose monitoring,weight gain and hypoglycemia remain major challenges and a constant source of concern for patients with type 1 diabetes.Type 1 diabetes shares some pathophysiology with type 2 diabetes,and an overlap has been reported.The above observation created great interest in glucagon-like peptide-1 receptor agonists(GLP-1)as adjuvants for type 1 diabetes.Previous trials confirmed the positive influence of GLP-1 agonists onβcell function.However,hypoglycemia unawareness and dysregulated glucagon response have been previously reported in patients with recurrent hypoglycemia using GLP-1 agonists.Jin et al found that the source of glucagon dysregulation due to GLP-1 agonists resides in the gut.Plausible explanations could be gut nervous system dysregulation or gut microbiota disruption.This review evaluates the potential of GLP-1 agonists in managing type 1 diabetes,particularly focusing on their impact on glycemic control,weight management,and glucagon dysregulation.We provide a broader insight into the problem of type 1 diabetes mellitus management in the light of recent findings and provide future research directions.

Role of intestinal glucagon-like peptide-1 in hypoglycemia response impairment in type 1 diabetes

This study critically examines the novel findings presented by Jin et al,which explores the role of intestinal glucagon-like peptide-1(GLP-1)in impaired counterregulatory responses to hypoglycemia in mice with type 1 diabetes.The study identifies intestinal GLP-1 as a significant determinant in the physiological responses to hypoglycemia,offering new insights into its potential implications for diabetes management.The editorial synthesizes these findings,discusses their relevance in the context of current diabetes research,and outlines potential avenues for future investigation of intestinal GLP-1 as a therapeutic target.This analysis underscores the need for continued research into the complex mechanisms underlying impaired hypoglycemia responses and highlights the potential of targeting intestinal GLP-1 pathways in therapeutic strategies for type 1 diabetes.

Relationship between hemoglobin glycation index and risk of hypoglycemia in type 2 diabetes with time-in-range in target

BACKGROUND In patients with type 2 diabetes mellitus(T2DM),the risk of hypoglycemia also occurs in at a time-in-range(TIR)of>70%.The hemoglobin glycation index(HGI)is considered the best single factor for predicting hypoglycemia,and offers new perspectives for the individualized treatment of patients with well-controlled blood glucose levels that are easily ignored in clinical settings.All participants underwent a 7-days continuous glucose monitoring(CGM)using a retrospective CGM system.We obtained glycemic variability indices using the CGM system.We defined HGI as laboratory hemoglobin A1c minus the glucose management indicator.Patients were categorized into low HGI(HGI<0.5)and high HGI groups(HGI≥0.5)according to HGI median(0.5).Logistic regression and receiver operating characteristic curve analyses were used to determine the risk factors for hypoglycemia.RESULTS We included 129 subjects with T2DM(54.84±12.56 years,46%male)in the study.Median TIR score was 90%.The high HGI group exhibited lower TIR and greater time below range with higher hemoglobin A1c than the low HGI group;this suggests more glycemic excursions and an increased incidence of hypoglycemia in the high HGI group.Multivariate analyses revealed that mean blood glucose,standard deviation of blood glucose and HGI were independent risk factors for hypoglycemia.Receiver operating characteristic curve analysis indicated that the HGI was the best predictor of hypoglycemia.In addition,the optimal cut-off points for HGI,mean blood glucose,and standard deviation of blood glucose in predicting hypoglycemia were 0.5%,7.2 mmol/L and 1.4 mmol/L respectively.CONCLUSION High HGI was significantly associated with greater glycemic excursions and increased hypoglycemia in patients with TIR>70%.Our findings indicate that HGI is a reliable predictor of hypoglycemia in this population.

Reading impairment after neonatal hypoglycemia with parietotemporo-occipital injury without cortical blindness:A case report

BACKGROUND Perinatal brain injury may lead to later neurodevelopmental disorders,whose outcomes may vary due to neuroplasticity in young children.Recent neuroimaging studies have shown that the left parietotemporal area(which includes the left inferior parietal lobe)is associated with phonological awareness and decoding skills,which are essential skills for reading acquisition in children.However,the literature on the effect of perinatal cerebral injury on the development of phonological awareness or decoding ability in childhood is limited.CASE SUMMARY We report the case of an 8-year-old boy who presented with reading difficulty following a perinatal injury in the parieto-temporal-occipital lobes.The patient was born at term and was treated for hypoglycemia and seizures during the neonatal period.Diffusion-weighted brain magnetic resonance imaging on postnatal day 4 revealed cortical and subcortical hyperintensities in the parieto-temporo-occipital lobe.At the age of 8 years,physical examination was unremarkable,aside from mild clumsiness.Despite occipital lobe injury,the patient had adequate visual acuity,normal eye movement,and no visual field defects.Full-scale intelligence quotient and verbal comprehension index on Wechsler Intelligence Scale for Children-Fourth Edition were 75 and 90,respectively.Further assessment revealed adequate recognition of Japanese Hiragana letters.However,he had significantly slower reading speed in the Hiragana reading test than control children.The phonological awareness test revealed significant errors(standard deviation+2.7)in the mora reversal task.CONCLUSION Patients with perinatal brain injuries in the parietotemporal area require attention and may benefit from additional reading instructions.

4R危机管理理论在结肠镜围检查期低血糖风险管理中的应用

目的探讨4R危机管理理论在结肠镜诊疗围检查期患者低血糖风险管理中应用的效果。方法采用便利抽样法,选择2022年3-12月在青岛市某三级甲等医院消化内科住院的372例行结肠镜诊疗的患者为对照组,采用结肠镜诊疗围检查期常规低血糖管理方法;选择2023年1-10月住院的372例行结肠镜诊疗的患者为观察组,实施基于4R危机管理理论的低血糖管理方案。比较2组患者结肠镜诊疗围检查期低血糖发生率、护士对结肠镜诊疗围检查期低血糖处置规范环节达标率、低血糖相关不良事件或并发症发生率的差异。结果观察组患者低血糖发生率低于对照组,护士对观察组患者低血糖处置规范环节达标率高于对照组,差异均具有统计学意义(P<0.05或P<0.001),2组患者低血糖相关不良事件或并发症发生率差异无统计学意义(P>0.05)。结论4R危机管理理论应用于结肠镜诊疗围检查期患者的低血糖管理中,能够有效降低患者低血糖发生率,提高护士对结肠镜诊疗围检查期低血糖处置正确率,值得在临床推广应用。

母婴同室护士对新生儿低血糖管理的认知现况调查

目的:了解母婴同室护士对新生儿低血糖管理的认知情况。方法:于2018年12月1日—2019年2月28日选取首都医科大学附属北京妇产医院母婴同室的121名护士作为研究对象,采用自行设计的调查问卷对护士进行调查。结果:121名护士中,所有护士均认为需要定期学习新生儿低血糖的相关知识,80.17%(97/121)的护士通过医院培训获取新生儿低血糖相关知识,80.17%的护士希望由新生儿科医师定期开展新生儿低血糖相关知识培训。护士对不同新生儿低血糖问题的认知正确率差异较大,为3.31%~95.87%,且工作年限≥5年的护士“您认为新生儿低血糖主要损害哪个脏器”“您认为母亲发生妊娠糖尿病的新生儿为什么容易发生低血糖”条目认知正确率高于工作年限<5年的护士,差异均有统计学意义(P<0.05)。结论:母婴同室护士,尤其是工作年限<5年的护士,对新生儿低血糖相关知识的认知相对不足,医院定期开展针对性培训十分必要。

Recurrent ciprofloxacin induced hypoglycemia in a non-diabetic patient:A case report

BACKGROUND Fluoroquinolones are a class of broad-spectrum antimicrobials used for various bacterial infections.Frequent use of fluoroquinolones has been questioned due to severe associated adverse effects,including dysglycemia(hypoglycemia or hyperglycemia)due to an alternation in glucose metabolism.Recent clinical trials showed the association of poor clinical outcomes with hypoglycemia in critically ill patients without diabetes.Many predisposing factors worsen fluoroquinolone-induced hypoglycemia,including diabetes,concomitant medication use like sulfonylureas or insulin,renal disease,and the elderly.CASE SUMMARY We report a case of recurrent hypoglycemia after ciprofloxacin initiation for a 71-year-old,non-diabetic,critically ill patient despite the presence of total parenteral nutrition and nasogastric tube feeding.The adverse drug reaction probability(Naranjo)scale was completed with a probable adverse drug reaction.The hypoglycemia resolved entirely after ciprofloxacin discontinuation.CONCLUSION Although ciprofloxacin-induced hypoglycemia is rare,special consideration is needed for the elderly due to their higher susceptibility to adverse side effects.

Oral Glucose Combined with Short-Term Intravenous Nutrition for the Prevention of Hypoglycemia after Painless Endoscopic Gastric Polypectomy

Objective: To explore the application effect of oral glucose combined with short-term intravenous nutrition in preventing postoperative hypoglycemia after painless endoscopic gastric polyp resection, and to provide guidance for better management of patients undergoing such procedures. Methods: A total of 886 patients who underwent painless endoscopic gastric polyp resection in the Department of Gastroenterology, the First Affiliated Hospital of Yangtze University, from January 2020 to December 2021, were selected as the study subjects. According to the random number table method, they were divided into an experimental group and a control group, with 443 cases in each group. Patients in the control group were subjected to routine fasting and water restriction for 8 hours before surgery, and routine fasting for 24 hours after surgery. Short-term intravenous nutrition support was provided through fluid supplementation, and finger blood glucose levels were monitored at 1 hour, 4 hours, and 8 hours after completion of intravenous infusion, or when symptoms such as palpitations and cold sweats occurred. The experimental group received oral administration of 5% glucose solution (500 ml) 2 hours before surgery based on the procedures of the control group. The incidence of preoperative discomfort (hunger, thirst, and fatigue), residual gastric fluid volume, and postoperative hypoglycemia were compared between the two groups. Results: The incidence of postoperative blood glucose Conclusion: Based on the study population, oral glucose combined with short-term intravenous nutrition can effectively prevent the incidence of hypoglycemia in patients undergoing painless endoscopic gastric polyp resection. However, due to the limitations of a single-center study and a small number of cases, its feasibility needs to be further validated with more data from multi-center and large-sample cases.

Oral Glucose Combined with Short-Term Intravenous Nutrition for the Prevention of Hypoglycemia after Endoscopic Colorectal Polypectomy

Objective: To investigate the effect of oral glucose combined with short-term intravenous nutrition on the prevention of hypoglycemia after endoscopic colorectal polypectomy and to provide guidance for better management of such patients. Methods: 860 patients who underwent endoscopic colorectal polypectomy for colorectal polyps in the Department of Gastroenterology of the First Affiliated Hospital of Yangtze University from January 2020 to December 2021 were selected for the study. The patients were divided into experimental and control groups according to the random number table method, with 430 patients in each group. In the control group, 3 L of polyethylene glycol electrolyte dispersion was used for preoperative intestinal preparation and postoperative fasting was performed routinely for 24 h. Short-term intravenous nutrition support was provided by rehydration, and finger blood glucose was monitored at 1, 4, and 8 h after intravenous infusion or when there were symptoms such as panic and cold sweat;in the experimental group, oral glucose intervention was implemented on the basis of the control group. The incidence of postoperative hypoglycemia, quality of bowel preparation, and tolerance of patients during bowel preparation were compared between the 2 groups. Results: The incidence of postoperative blood glucose Conclusion: Based on the present study population, oral glucose combined with short-term intravenous nutrition can effectively prevent the incidence of hypoglycemia in patients after endoscopic colorectal polypectomy;however, this was limited to a single-center study and the number of cases was small.

甲泼尼龙致重症肌无力患者严重低血糖的病例分析

1例50岁男性重症肌无力患者,先后给予溴吡斯的明片改善肌无力症状,甲泼尼龙片、吗替麦考酚酯胶囊抑制免疫,奥美拉唑肠溶片和碳酸钙D_(3)片预防激素相关不良反应等治疗。患者无糖尿病史,入院后测空腹血糖4.92 mmol/L。甲泼尼龙片治疗1周后,空腹血糖降至3.56 mmol/L。甲泼尼龙片治疗11 d后,空腹血糖低至2.80 mmol/L。排除其他药物后,考虑低血糖由甲泼尼龙引起的可能性大。因病情需要,且患者未诉大汗、心悸等低血糖症状,未予停药处理。随访2个月,患者甲泼尼龙逐渐减量,多次复查,血糖逐渐恢复至正常范围。

新生儿低血糖风险预测模型的构建及效果验证

目的构建新生儿发生低血糖临床风险因素及构建预测模型,为早期识别新生儿低血糖提供理论参考。方法选取2020年1月—2022年1月南京市某医院1330例新生儿为研究对象,按7:3分为建模组(n=931)、验证组(n=399)。利用Logistic回归构建模型,Hosmer-Lemeshow、ROC等评价拟合优度、预测效果。结果新生儿低血糖发生率在建模组与验证组中分别为12.57%(117/931)、12.78%(44/399),二者之间比较差异无统计学意义(P>0.05)。母亲合并糖尿病、母亲肥胖、孕期及哺乳期服用β受体阻滞剂药物、产前使用皮质类固醇类药物、小于胎龄、血糖检测方式6个因素是独立影响因素。建模组模型ROC曲线下面积0.893(95%CI:0.855~0.931,P=0.000),H-L检验结果为P=0.155,验证组曲线下面积占比0.847(95%CI:0.828~0.9876,P=0.000),H-L检验结果P=0.401。结论本模型预测效果良好,可有效预测新生儿低血糖并划分层级,为新生儿低血糖的临床护理提供理论依据。

甜玉米芯多糖铁配合物的工艺优化及体外活性

甜玉米芯多糖(SCP80)与三氯化铁共热合成了甜玉米芯多糖铁配合物(SCP),在单因素实验基础上,采用响应面法优化了SCP制备工艺。通过SEM、XRD、TG、纳米粒度及Zeta电位分析仪、UV-Vis和FTIR对SCP进行了形貌和结构表征,并测定了其体外抗氧化及降糖活性。结果表明,50 mL质量浓度为1 g/L的SCP80水溶液合成SCP的最佳合成工艺为:反应温度75℃、反应时间64.6 min、pH=8.5、m(SCP80)∶m(柠檬酸三钠)=3.64∶1。在该条件下制备的SCP中铁质量分数为27.89%±0.35%。与SCP80相比,SCP表面更光滑,粒径从43.8 nm(SCP80)增至164.0 nm,具有更好的热稳定性,更好的清除羟基自由基能力和还原能力,质量浓度为4.0 g/L的SCP对羟基自由基的清除率为57.51%;SCP对α-淀粉酶半抑制浓度(IC_(50))为(1.20±0.11) g/L,对α-葡萄糖苷酶的IC_(50)为(0.92±0.07) g/L,其体外降糖活性明显优于SCP80。

品管圈活动在降低内镜黏膜切除术术后48 h内低血糖发生率中的应用效果

目的探讨品管圈活动在降低内镜黏膜切除术(EMR)术后48 h内低血糖发生率中的应用效果。方法回顾性选取2023年4月至9月在首都医科大学附属北京世纪坛医院消化内科住院行EMR的胃肠息肉患者600例作为研究对象。将未实施品管圈(2023年4月至6月)的325例患者作为对照组,将实施品管圈(2023年7月至9月)的275例患者作为观察组。对照组按照常规护理进行管理,观察组在对照组的基础上开展品管圈活动。比较两组患者EMR术后48 h内低血糖的发生率及影响因素、生命质量评分的差异,分析开展品管圈活动在降低ERM术后48 h内低血糖中的实践成果。结果观察组低血糖发生率为4.4%,明显低于对照组(10.8%),差异有统计学意义(P<0.05)。影响低血糖发生率的因素中,观察组输液不合理、摄入不足的患者比例分别为0.7%、1.5%,均低于对照组(4.3%、4.9%),差异均有统计学意义(P<0.05)。干预后,观察组患者生理功能、生理职能、躯体疼痛、一般健康状况、心理健康、精力、社会功能、情感职能评分分别为(86.94±7.32)、(84.18±7.03)、(83.00±5.96)、(82.91±6.39)、(80.42±6.11)、(78.45±7.35)、(82.69±6.72)、(80.71±6.17)分,均明显高于对照组[(81.77±11.67)、(78.09±10.97)、(76.50±9.64)、(76.75±9.86)、(75.80±7.30)、(72.38±9.97)、(76.86±9.97)、(75.94±7.61)分],差异均有统计学意义(P<0.05)。通过此次品管圈活动,圈员们在品管圈手法掌握程度、发现问题能力、个人素质、责任心、组织协调能力、自信心、团队合作精神等方面都取得了进步。结论通过开展品管圈活动,规范了EMR的护理流程,降低了EMR术后48 h内低血糖的发生率,提升了护理人员的专业知识水平、品管圈的手法运用能力和团队协作及质量管理能力。

“3+1”方案与预混胰岛素治疗2型糖尿病的临床比较

目的分析2型糖尿病应用“3+1”方案与预混胰岛素治疗的临床效果。方法选取2022年8月—2023年8月滨州医学院附属医院全科医学科收治的88例2型糖尿病患者为研究对象,根据治疗方法不同分为参照组与观察组,各44例。参照组给予预混胰岛素治疗,观察组给予“3(早、中、晚餐前门冬胰岛素30皮下注射)+1(睡前甘精胰岛素皮下注射)”方案治疗,对比两组血糖指标[空腹血糖(fasing plasma glucose,FPG)、餐后2 h血糖(2-hour postprandial plasma glucose,2 hPG)、糖化血红蛋白(glycated hemoglobin A1c,HbAlc)]水平、血糖波动情况[血糖水平标准差(standard deviation of blood glucose level,SDBG)、餐后血糖波动幅度(postprandial glu-cose fluctuation amplitude,PPGE)、四分位血糖波动范围(interquartile range of glucose fluctuation,IQR)、变异系数(coefficient of variation,CV)]、血糖达标时间、胰岛素用量、低血糖发生率。结果治疗后,两组血糖水平均低于治疗前,且观察组低于参照组,差异有统计学意义(P均<0.05)。相较于治疗前,两组治疗后SDBG、PPGE、IQR均降低,CV增大,且与参照组比较,观察组治疗后SDBG、PPGE、IQR更低,CV更大,差异有统计学意义(P均<0.05)。观察组胰岛素用量少于参照组,血糖达标时间短于参照组,差异有统计学意义(P均<0.05)。观察组低血糖发生率低于参照组,差异有统计学意义(P<0.05)。结论“3+1”方案治疗2型糖尿病的临床效果优于预混胰岛素,能够降低血糖水平,加快降低血糖水平,安全性高。

曲马多诱导的低血糖的临床特征分析

目的:探讨曲马多诱导的低血糖的临床特点。方法:通过检索中英文数据从建库起至2023年4月28日,收集曲马多诱导的低血糖的病例报告。结果:20例患者被纳入,中位年龄为50岁(4,88)。低血糖发生在给药后1 h~23 d,血糖的中位值为2.25 mmol/L(0.22,3.3),曲马多的中位日剂量为300 mg(1.53,14000)。临床主要表现为昏迷(12例),多器官功能衰竭(7例),心肺骤停(7例),癫痫发作(4例),嗜睡(3例)和出汗(3例)等。6例患者报告了曲马多血药浓度,中位值为3.56 mg/L(0.47,9.4)。20例患者停用曲马多,给予对症支持治疗后,16例患者恢复,1例患者中度脑功能障碍,3例患者死亡。结论:曲马多诱导的低血糖可发生在给药后1 h~23 d,临床可表现为自主神经系统症状和神经低血糖症状,以神经低血糖症状为主。停用曲马多后大部分患者低血糖可恢复正常,严重者可死亡。

急诊护理干预对老年糖尿病伴低血糖昏迷患者血糖水平及救治成功率的影响

目的探讨急诊护理干预对老年糖尿病伴低血糖昏迷患者血糖水平及救治成功率的影响。方法采用方便抽样法选取2020年1月至2021年12月在本院急诊科收治的老年糖尿病伴低血糖昏迷患者38例作为A组,将2022年1月至2023年6月在本院急诊科收治的老年糖尿病伴低血糖昏迷患者69例作为B组。A组采用常规护理,B组采用急诊护理。统计两组入院急救时间、住院时间、血糖指标、抢救成功率、并发症发生率、患者满意度。结果B组入院急救时间、住院时间均短于A组(P<0.05);干预后B组FPG、2hPG、HbA1c水平低于A组(P<0.05);B组抢救成功率高于A组(P<0.05),并发症发生率低于A组(P<0.05);B组护理满意度高于A组(P<0.05)。结论在老年糖尿病伴低血糖昏迷患者中进行急诊护理干预能够有效降低血糖水平,提高抢救成功率,减少并发症的发生率,缩短入院急救时间和住院时间,且患者满意度较高,具有一定的临床价值和推广意义。

糖尿病新生儿发生低血糖的危险因素分析

目的分析糖尿病新生儿发生低血糖的危险因素。方法选取2021年6月—2023年10月晋江市医院(上海市第六人民医院福建医院)收治的80例糖尿病新生儿作为研究对象,根据患儿是否存在低血糖现象分为参照组(不存在低血糖,n=40)、观察组(存在低血糖,n=40)。检测患儿出生48 h血糖水平并开展问卷调查,从而进行单因素分析、Logistic多因素分析。结果Logistic回归分析结果显示,影响糖尿病新生儿出生后低血糖产生的因素较多,主要包括新生儿出生体质量、母亲年龄、母亲妊娠期增加体质量(P均<0.05)。结论糖尿病新生儿出生48 h内比较容易出现反复低血糖现象,其中新生儿出生体质量、母亲年龄、母亲妊娠期增加体质量均为糖尿病新生儿低血糖产生的独立影响因素,应重点关注该类新生儿并提供有效干预,降低其低血糖发生概率。